Private equity and artificial intelligence are two of the most controversial issues in gastroenterology, according to five gastroenterologists who spoke to Becker’s ASC Review.
Editor’s note: Responses were lightly edited for clarity and brevity.
Samuel Giordano, MD, of Cooper University Health Care (Willingboro, N.J.): I think the most controversial trend in gastroenterology today is navigating and implementing the usage of artificial intelligence technology to help assist endoscopists with polyp detection. It is clear, based on the early data, that there is an opportunity for practice improvement and evolution, but the tricky part is the implementation. There are several companies that are competing right now in the AI technology realm and trying to become the “gold standard” in AI technology as it relates to gastroenterology. It will be interesting to see how this competition settles out and how soon we can implement the technology into our daily practice. This is extremely exciting for both patients and practitioners to have the ability to improve what’s considered by some the “gold standard” procedure in screening and prevention and make it even better.